NCT00625846: A trial that was reported late by National Cancer Institute (NCI)
This trial has reported, although it was 45 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT00625846 |
|---|---|
| Title | A Phase II Study of GW 786034 (Pazopanib) in Advanced Thyroid Cancer |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Feb. 22, 2008 |
| Completion date | Dec. 21, 2018 |
| Required reporting date | Dec. 21, 2019, midnight |
| Actual reporting date | Feb. 4, 2020 |
| Date last checked at ClinicalTrials.gov | Aug. 12, 2025 |
| Days late | 45 |